Artiva Biotherapeutics, Inc.

ARTV · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$40,235$53,504$102,531$160,923
Short-Term Investments$145,193$23,467$0$0
Receivables$146$1,758$525$468
Inventory$0$0$0$0
Other Curr. Assets$3,057$1,092$1,619$896
Total Curr. Assets$188,631$79,821$104,675$162,287
Property Plant & Equip (Net)$20,425$24,643$27,612$4,078
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$525$650$762$3,561
Total NC Assets$20,950$25,293$28,374$7,639
Other Assets$0$0$5$0
Total Assets$209,581$105,114$133,054$169,926
Liabilities
Payables$1,121$614$1,096$1,444
Short-Term Debt$3,740$3,596$3,486$433
Tax Payable$0$0$0$0
Deferred Revenue$0$0$10,891$7,295
Other Curr. Liab.$7,392$8,017$10,152$10,133
Total Curr. Liab.$12,253$12,227$25,625$19,305
LT Debt$10,614$13,316$15,962$1,308
Deferred Rev, NC$0$0$15,635$21,677
Deferred Tax Liab, NC$0$0$216,413$216,413
Other NC Liab.$73$241,586$115$81
Total NC Liab.$10,687$254,902$248,125$239,479
Other Liabilities$0$0$0$0
Cap. Leases$14,354$16,912$19,448$1,741
Total Liabilities$22,940$267,129$273,750$258,784
Equity
Pref Stock$0$0$0$0
Common Stock$3$0$0$0
Retained Earnings-$246,684-$181,311-$152,591-$93,803
AOCI-$129$308$0$0
Other Equity$433,451$18,988$11,895$4,945
Total Equity$186,641-$162,015-$140,696-$88,858
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$209,581$105,114$133,054$169,926
Net Debt-$25,881-$36,592-$83,083-$159,182
Artiva Biotherapeutics, Inc. (ARTV) Financial Statements & Key Stats | AlphaPilot